Sertraline 50 mg

DRUG2 trials

Sponsors

Federico II University, London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Conditions

Burning Mouth SyndromeChronic Kidney Disease (CKD)ElderlyOutpatient

Phase 3

Comparison of Vortioxetine Versus Other Antidepressants With Pregabalin Augmentation in Burning Mouth Syndrome

Federico II UniversityBurning Mouth Syndrome

Start: 2023-01-01End: 2024-07-24Target: 203Updated: 2023-09-06

Unknown Phase

Sertraline and the Risk of Serious Adverse Events

CompletedNCT07387120

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sChronic Kidney Disease (CKD), Elderly, Outpatient

Start: 2008-01-01End: 2026-01-01Updated: 2026-02-04

Related Papers

Vortioxetine versus SSRI/SNRI with Pregabalin Augmentation in Treatment-Resistant Burning Mouth Syndrome: A Prospective Clinical Trial

Current Neuropharmacology2025-02-283 citations